Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies (Q33399543)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies |
scientific article |
Statements
1 reference
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies (English)
1 reference
Wyndham H Wilson
1 reference
Seth M Steinberg
1 reference
Steven Z Pavletic
1 reference
Kieron Dunleavy
1 reference
Rachel B Salit
1 reference
Daniel H Fowler
1 reference
Robert M Dean
1 reference
Frances Hakim
1 reference
Terry J Fry
1 reference
Thomas E Hughes
1 reference
Jeanne Odom
1 reference
Kelly Bryant
1 reference
Ronald E Gress
1 reference
Michael R Bishop
1 reference
6 February 2012
1 reference
1 reference
30
1 reference
830-836
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference